Co-Diagnostics, Inc. (CODX) will implement a one-for-twenty-five (1-25) reverse stock split effective Tuesday, November 24, 2026. Alongside the split, the company's CUSIP number will change to 189763303. The action, confirmed by Nasdaq, is a mechanical adjustment that reduces the number of shares while proportionally increasing the per-share price.
Nasdaq confirms CODX will effect a one-for-twenty-five (1-25) reverse stock split effective Tuesday, November 24, 2026, with a CUSIP change to 189763303. A reverse split is mechanically share-price neutral, but companies typically undertake one to raise a low share price, which can be read as a weak-fundamentals signal. No earnings, guidance or business news accompanies the alert.
- • One-for-twenty-five (1-25) reverse stock split effective November 24, 2026
- • CUSIP number change to 189763303
- • Reverse splits are often undertaken by companies with depressed share prices and may be perceived as a negative signal
- • CUSIP change requires market participants to update records, which can cause short-term administrative friction